2022 annual financial data
Oramed Pharmaceuticals 2022 Operating margin
Oramed Pharmaceuticals 2022 operating margin with verified reported values.
Direct answer
Operating margin was -1,501.96%.
Operating income was -40,598,000 USD and net income was -37,764,000 USD.
Operating cash flow was -28,701,000 USD.
Get free Oramed Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,703,000 USD
- Operating income
- -40,598,000 USD
- Net income
- -37,764,000 USD
- Operating cash flow
- -28,701,000 USD